Tibsovo (ivosidenib)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Tibsovo (ivosidenib), covering 2025-12-15 to 2026-03-23. Get the full timeline:
Most recent: Clinical Trial Update: Phase II Study Evaluating Ivosidenib Maintenance After SOC Adjuvant Chemotherapy in Curative mIDH1 Cholangiocarcinoma [Phase 2]